Cat. No. | Product name | CAS No. |
DC9863 |
Dinoprost
Featured
Dinoprost(Prostaglandin F2α) is a naturally occurring prostaglandin used in medicine to induce labor and as an abortifacient. |
551-11-1 |
DCAPI1702 |
Diphemanil methylsulfate
Featured
Diphemanil Methylsulfate is a quaternary ammonium anticholinergic, it binds muscarinic acetycholine receptors (mAchR). |
62-97-5 |
DC10683 |
DL 071-IT hydrochloride
DL 071-IT is a potent non-selective beta-adrenoceptor antagonist. |
55104-39-7 |
DC9323 |
Dalasetron (Mesylate hydrate)
Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy. |
878143-33-0 |
DC11103 |
Tavapadon
Featured
Tavapadon is a potent, orally-bioavailable, selective partial agonist of the dopamine D1 and D5 receptors. |
1643489-24-0 |
DC9109 |
Doxylamine succinate
Doxylamine is a first generation antihistamine; can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief. |
562-10-7 |
DC10039 |
DREADD Agonist 21
Featured
DREADD agonist 21 is a potent muscarinic hM3Dq DREADD agonist (EC50 = 1.7 nM). Highly selective for hM3Dq DREADDs over endogenous hM3 receptors. |
56296-18-5 |
DC11233 |
DS-8500a
DS-8500a (DS8500a) is a novel potent, selective, orally available GPR119 agonist with EC50 of 51.5 nM in human GPR119-expressing CHO-K1 cells, displays no significant effect on 66 receptors, channels, or transporters. |
1371591-51-3 |
DC8533 |
E5555 hydrobromide
E5555 shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 μM respectively. |
474550-69-1 |
DC10563 |
E-7046
Featured
E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM, exhibiting anti-tumor activities. |
1369489-71-3 |
DC8323 |
Eletriptan HBr
Featured
Eletriptan HBr is an orally active, selective 5-HT1B/1D receptor agonist. |
177834-92-3 |
DC7772 |
Elinogrel
Elinogrel is a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events. |
936500-94-6 |
DC8626 |
Eluxadoline
Featured
Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist. |
864821-90-9 |
DC10869 |
Olodanrigan(EMA401)
Featured
EMA401(Olodanrigan) is a highly selective AT2R antagonist, inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons. |
1316755-16-4 |
DC11028 |
EMD-281014 hydrochloride
EMD-281014 hydrochloride is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM, displays little to no affinity for 5-HT2C receptors (Ki=557 nM), human D2 receptors and IKr channels. |
443144-27-2 |
DC11027 |
EMD-281014
EMD-281014 is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM, displays little to no affinity for 5-HT2C receptors (Ki=557 nM), human D2 receptors and IKr channels. |
443144-26-1 |
DC9467 |
Epinastine
Featured
Epinastine(WAL801) is an antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. |
80012-43-7 |
DC9260 |
Eptapirone
Featured
Eptapirone (F-11,440) is a very potent and highly selective 5-HT1A receptor full agonist of the azapirone family. |
179756-58-2 |
DC9016 |
Etamsylate
Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins. |
2624-44-4 |
DC10040 |
Etrasimod(APD334)
Featured
Etrasimod (APD334) is a potent, selective and orally available antagonist of the sphingosine-1-phosphate-1(S1P1) receptor with an IC50 value of 1.88 nM in CHO cells. |
1206123-37-6 |
DC9685 |
Evatanepag (CP-533536)
Featured
Evatanepag (CP-533536) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM. |
223488-57-1 |
DC9073 |
Famotidine
Famotidine is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. |
76824-35-6 |